Determining the lower limit of detection required for HCV viral load assay for test of cure following direct-acting antiviral-based treatment regimens: Evidence from a global data set

Morgan, JR; Marsh, E; Savinkina, A; Shilton, S; Shadaker, S; Tsertsvadze, T; Kamkamidze, G; Alkhazashvili, M; Morgan, T; Belperio, P; Backus, L; Doss, W; Esmat, G; Hassany, M; Elsharkawy, A; Elakel, W; Mehrez, M; Foster, GR; Kinge, CW; Chew, KW; Chasela, CS; Sanne, IM; Thanung, YM; Loarec, A; Aslam, K; Balkan, S; Easterbrook, PJ; Linas, BP

Morgan, JR (通讯作者)，Boston Univ, Sch Publ Hlth, Dept Hlth Law Policy & Management, Boston, MA 02215 USA.

JOURNAL OF VIRAL HEPATITIS, 2022; 29 (6): 474

Abstract

Achieving global elimination of hepatitis C virus requires a substantial scale-up of testing. Point-of-care HCV viral load assays are available as an ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索